Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP535480.RAHIDkYIMVzCPgrxZYyzN0QZv3glMcddNb7HrpIdIhk5Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP535480.RAHIDkYIMVzCPgrxZYyzN0QZv3glMcddNb7HrpIdIhk5Q130_assertion type Assertion NP535480.RAHIDkYIMVzCPgrxZYyzN0QZv3glMcddNb7HrpIdIhk5Q130_head.
- NP535480.RAHIDkYIMVzCPgrxZYyzN0QZv3glMcddNb7HrpIdIhk5Q130_assertion wasGeneratedBy ECO_0000203 NP535480.RAHIDkYIMVzCPgrxZYyzN0QZv3glMcddNb7HrpIdIhk5Q130_provenance.
- NP535480.RAHIDkYIMVzCPgrxZYyzN0QZv3glMcddNb7HrpIdIhk5Q130_assertion wasDerivedFrom befree-2016 NP535480.RAHIDkYIMVzCPgrxZYyzN0QZv3glMcddNb7HrpIdIhk5Q130_provenance.
- NP535480.RAHIDkYIMVzCPgrxZYyzN0QZv3glMcddNb7HrpIdIhk5Q130_assertion SIO_000772 16472146 NP535480.RAHIDkYIMVzCPgrxZYyzN0QZv3glMcddNb7HrpIdIhk5Q130_provenance.
- NP535480.RAHIDkYIMVzCPgrxZYyzN0QZv3glMcddNb7HrpIdIhk5Q130_assertion evidence source_evidence_literature NP535480.RAHIDkYIMVzCPgrxZYyzN0QZv3glMcddNb7HrpIdIhk5Q130_provenance.
- NP535480.RAHIDkYIMVzCPgrxZYyzN0QZv3glMcddNb7HrpIdIhk5Q130_assertion description "[Indeed, the first clinical gene therapy trial was safely performed and was in part, effective for adenosine deaminase (ADA) deficiency patients, a type of severe combined immunodeficiency diseases (SCID).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP535480.RAHIDkYIMVzCPgrxZYyzN0QZv3glMcddNb7HrpIdIhk5Q130_provenance.